Researchers from Tikkunlev Therapeutics Inc. and the University of Utah have presented preclinical data on TLT-101, a gene therapy consisting of an adeno-associated virus serotype 9 (AAV9) vector ...
ZURICH, July 19 (Reuters) - Shares in Swiss biotech group Arpida gained ground on Thursday, as investors welcomed news the group had acquired Switzerland's TLT Medical, bringing a late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results